MedPath

The acute effects of Yohimbine on fear conditioning and the neural processing of emotional images, and on delayed extinction learning and memory for the images.

Phase 4
Conditions
Healthy subjects, investigating the mechanisms underpinning Post Traumatic Stress Disorder
Mental Health - Studies of normal psychology, cognitive function and behaviour
Registration Number
ACTRN12611000820909
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Healthy University Students.
Right handed.

Exclusion Criteria

Current course of medication (including hormonal contraceptive for female participants), pregnancy or breasfeeding, substance abuse / dependence, current or recent history of psychiatric conditions, current or recent medical conditions, suicidal thoughts, known sensitivity to Hydrocortisone or Yohimbine, post-menopausal (for female participants), any participants with metal implants in the body. Participants are instructed not to drink alcohol or take any illegal drugs on the day of drug administration, and to abstain from fluids and food for two hours prior to drug administration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath